Protek Group topped the list of pharmaceutical companies in the rating “200 largest private companies in Russia
Protek Group with a revenue of 265.6 billion rubles in 2019 was ranked 34th in the annual rating “200 largest private companies in Russia”, published on 17 September on the website of the Russian edition of Forbes magazine.
The rating also includes six more pharmaceutical companies: Katren - 39th place, Pulse - 43rd place, Pharmstandard - 69th place, R-Pharm - 142nd place, Pharmkomplekt - 171st place, and Pharmperspektiva - 192nd place.
“In 2019, Protek Group once again proved its leadership in Russian pharmaceuticals, which indicates the correct choice of strategy to strengthen the group’s presence in all segments of the industry - production, distribution and retail. The constant search for new opportunities is the main factor that allows Protek Group to move forward”, said Vadim Muzyaev, the President of Protek Group.
The rating “200 largest private companies in Russia” includes companies controlled by private individuals (more than 50%). Companies are ranked by revenue for 2019. Preference is given to IFRS data.
Construction began on a new facility of CV Protek’s logistics park near Moscow
At the end of July, construction began on a new customs warehouse terminal TST-3, constructions works for TST-4... more...
Distribution and retail segments of Protek Group recognized as the most influential players in the pharmaceutical market
CV Protek (Protek Group distribution segment) and Rigla Pharmacy Chain (Protek Group retail segment) were recognized a... more...
Protek’s CFO Mikhail Danilov Featured in Choiseul 100 Russia Rating
CV Protek’s CFO Mikhail Danilov was features in Choiseul 100 Russia rating of young economic leaders by the French ind... more...